Case report: Pragmatic impairment in multiple sclerosis after worsening of clinical symptoms

Sara Lago1,2, Francesca Bevilacqua1, Maria Rosaria Stabile3

  • 1IRCCS San Camillo Hospital, Venice, Italy.

Frontiers in Psychology
|December 12, 2022
PubMed

Insights

Pragmatic language abilities can decline in Multiple Sclerosis (MS) patients, particularly after clinical worsening. This highlights the need for regular pragmatic assessments in MS care.

Area of Science:

  • Neurology
  • Linguistics
  • Cognitive Science

Background:

  • Pragmatics, the integration of language and context for effective communication, is crucial for social interaction.
  • Potential pragmatic impairments in Multiple Sclerosis (MS) warrant further investigation.
  • Understanding cognitive changes in MS is vital for patient management.

Observation:

  • A patient with active secondary progressive MS experienced a sudden clinical decline, treated with corticosteroids.
  • Initial neuropsychological assessment revealed only slight pragmatic deficits.
  • Following clinical worsening, a significant decline in pragmatic comprehension and production was observed.

Findings:

  • The patient's pragmatic abilities deteriorated markedly after the clinical worsening.
  • This decline was specific to pragmatics, with only one attention task also affected.
  • Overall cognitive functioning remained relatively stable, suggesting a targeted impact on pragmatics.

Implications:

  • Pragmatic language skills may be a sensitive indicator of cognitive decline in MS.
  • The findings underscore the importance of including pragmatic assessments in routine clinical evaluations for MS patients.
  • Targeted interventions for pragmatic deficits could improve communication and quality of life in MS.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
650
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
108
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
185